Keating Financial Advisory Services, Inc.
Position in NPCE — NeuroPace Inc
CIK 2103443
MANHATTAN, KS
Position in NPCE
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$270
+$231 QoQ
Shares Held
17
+466.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#101
of 112 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NPCE Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Keating Financial Advisory Services, Inc. holds $897,823 across 35 Medical Devices names. NPCE ranks #34 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
3,516 | $319,041 | |
| 2 | SYK |
Stryker Corp
|
693 | $218,184 | |
| 3 | ZBH |
Zimmer Biomet Holdings, Inc.
|
624 | $53,720 | |
| 4 | BSX |
Boston Scientific Corp
|
1,094 | $46,691 | |
| 5 | EW |
Edwards Lifesciences Corp
|
431 | $38,988 | |
| 6 | STE |
STERIS plc
|
158 | $33,270 | |
| 7 | PEN |
Penumbra Inc
|
97 | $30,627 | |
| 8 | MDT |
Medtronic plc
|
381 | $29,805 |
All Filings in NPCE
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $270 | 17 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $39 | 3 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||